Treatment of gram-negative bacillary septicemia with cefoperazone.
about
Continuous versus intermittent infusions of antibiotics for the treatment of severe acute infectionsDoes prolonged β-lactam infusions improve clinical outcomes compared to intermittent infusions? A meta-analysis and systematic review of randomized, controlled trials.What do we really know about antibiotic pharmacodynamics?Pharmacodynamics of ceftazidime administered as continuous infusion or intermittent bolus alone and in combination with single daily-dose amikacin against Pseudomonas aeruginosa in an in vitro infection model.Continuous infusion versus intermittent administration of ceftazidime in critically ill patients with suspected gram-negative infectionsSingle-drug versus combination empirical therapy for gram-negative bacillary infections in febrile cancer patients with and without granulocytopeniaContinuous infusion of beta-lactam antibioticsContinuous beta-lactam infusion in critically ill patients: the clinical evidenceβ-lactam pharmacokinetics and pharmacodynamics in critically ill patients and strategies for dose optimization: a structured review.Continuous and Prolonged Intravenous β-Lactam Dosing: Implications for the Clinical Laboratory.Beta-lactam antibiotics: is continuous infusion the preferred method of administration?Continuous infusion of antibiotics in the critically ill: The new holy grail for beta-lactams and vancomycin?Cost-effectiveness of ceftazidime by continuous infusion versus intermittent infusion for nosocomial pneumonia.Outpatient parenteral antimicrobial therapy (OPAT) for the treatment of osteomyelitis: evaluation of efficacy, tolerance and cost.
P2860
Q24199096-3D0C4105-0A42-4A91-AE7A-67091579331BQ33940174-8D4960EE-BB8A-49CB-BD9A-5CE577FBD32DQ34443407-3D6EC624-01C7-4AC5-83B0-6551CE2AE7E4Q35117352-4EB023CF-EE4B-4789-A1DC-74E8A141B1D8Q35123123-DDD3F331-DA49-42CC-828E-4EE964D699B0Q35641123-BD22E0CA-0630-4020-9EE2-452CF2F3E900Q35656806-8BA1DD21-41E9-4109-BAD4-44052A559BDDQ36329228-069871AD-DAB5-45A6-B270-B6C743C11975Q38004063-E9489E86-9966-4B00-A30E-6211724F1E81Q38896040-A4CB2041-A5AC-4134-9BC9-125EA64286EFQ40459002-1CE15633-E5FB-41D8-A3AF-3302F37EAC7EQ42432137-6D49CD1A-F134-400B-8073-58BFE5559711Q43410703-7C170964-1040-4CC7-8BE0-CDD55640F469Q43808736-80154F1F-1C91-41EE-A7EE-CBD32521B0F2
P2860
Treatment of gram-negative bacillary septicemia with cefoperazone.
description
1983 nî lūn-bûn
@nan
1983年の論文
@ja
1983年学术文章
@wuu
1983年学术文章
@zh-cn
1983年学术文章
@zh-hans
1983年学术文章
@zh-my
1983年学术文章
@zh-sg
1983年學術文章
@yue
1983年學術文章
@zh
1983年學術文章
@zh-hant
name
Treatment of gram-negative bacillary septicemia with cefoperazone.
@en
Treatment of gram-negative bacillary septicemia with cefoperazone.
@nl
type
label
Treatment of gram-negative bacillary septicemia with cefoperazone.
@en
Treatment of gram-negative bacillary septicemia with cefoperazone.
@nl
prefLabel
Treatment of gram-negative bacillary septicemia with cefoperazone.
@en
Treatment of gram-negative bacillary septicemia with cefoperazone.
@nl
P2093
P2860
P356
P1476
Treatment of gram-negative bacillary septicemia with cefoperazone.
@en
P2093
F Meunier-Carpentier
J Klastersky
P2860
P304
P356
10.1007/BF02016564
P577
1983-12-01T00:00:00Z